HOME › DRUGS › PANDEMIC INFLUENZA VACCINE (H5N1) (LIVE ATTENUATED, NASAL)
ACTIVE SUBSTANCE / INN

PANDEMIC INFLUENZA VACCINE (H5N1) (LIVE ATTENUATED, NASAL)

Brand name(s): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune)
EMA LISTED
AUTHORISED
Influenza, Human
ACTIVE SUBSTANCE
Pandemic Influenza Vaccine (H5N1) (Live Attenuated, Nasal)
REGULATORS
EMA
SPONSORS / MAH
AstraZeneca AB
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune)AstraZeneca ABAuthorised20/05/2016Influenza, Human

FULL INTELLIGENCE ON PANDEMIC INFLUENZA VACCINE (H5N1) (LIVE ATTENUATED, NASAL)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →